BRUNELLI, Matteo
 Distribuzione geografica
Continente #
EU - Europa 12.651
NA - Nord America 12.412
AS - Asia 5.744
SA - Sud America 87
AF - Africa 86
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 13
Totale 31.022
Nazione #
US - Stati Uniti d'America 12.169
GB - Regno Unito 4.175
CN - Cina 3.622
IT - Italia 1.892
SG - Singapore 1.527
SE - Svezia 1.350
RU - Federazione Russa 1.125
IE - Irlanda 1.077
FR - Francia 931
DE - Germania 925
FI - Finlandia 656
CA - Canada 229
UA - Ucraina 206
BE - Belgio 104
KR - Corea 100
VN - Vietnam 94
JP - Giappone 84
TR - Turchia 73
HK - Hong Kong 62
TG - Togo 60
BR - Brasile 48
NL - Olanda 48
ID - Indonesia 28
IN - India 28
AU - Australia 26
IR - Iran 22
AT - Austria 19
ES - Italia 17
CL - Cile 13
CZ - Repubblica Ceca 13
LV - Lettonia 13
PL - Polonia 13
CH - Svizzera 10
EC - Ecuador 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
EU - Europa 8
IL - Israele 8
LK - Sri Lanka 8
LT - Lituania 8
TW - Taiwan 8
EG - Egitto 7
GR - Grecia 7
HU - Ungheria 7
MA - Marocco 7
MY - Malesia 7
PK - Pakistan 7
PT - Portogallo 7
AM - Armenia 6
AZ - Azerbaigian 6
IM - Isola di Man 6
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
PA - Panama 6
PE - Perù 6
AR - Argentina 5
EE - Estonia 5
DK - Danimarca 4
HR - Croazia 4
KE - Kenya 4
RO - Romania 4
SA - Arabia Saudita 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BD - Bangladesh 3
BO - Bolivia 3
CO - Colombia 3
JO - Giordania 3
MT - Malta 3
MX - Messico 3
NZ - Nuova Zelanda 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
CM - Camerun 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KZ - Kazakistan 2
MK - Macedonia 2
NO - Norvegia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
A1 - Anonimo 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 31.022
Città #
Southend 3.738
Chandler 2.472
Jacksonville 1.328
Singapore 1.266
Dublin 1.067
Woodbridge 1.067
Ann Arbor 960
Beijing 732
Ashburn 685
Houston 447
Lawrence 367
Princeton 367
New York 350
Wilmington 345
Verona 332
Jinan 330
Helsinki 262
Nanjing 244
Shenyang 225
Munich 205
Montréal 195
Mcallen 179
Hebei 175
Sindelfingen 134
Dearborn 131
Tianjin 129
Milan 121
Zhengzhou 120
Redmond 118
Ningbo 102
Brussels 99
Seoul 97
Rome 94
Changsha 93
Taizhou 93
Boardman 91
Bologna 91
Seattle 91
Haikou 88
Santa Clara 85
Guangzhou 81
Nanchang 79
Redwood City 74
Tokyo 74
Taiyuan 69
Lancaster 66
Los Angeles 66
Jiaxing 65
Hangzhou 62
Lomé 60
Dong Ket 57
Hong Kong 53
Norwalk 51
Volga 47
Moscow 42
Dallas 40
Fairfield 38
Lanzhou 37
Kent 35
Washington 34
Chicago 33
Detroit 33
Falls Church 29
Düsseldorf 28
Fuzhou 28
Jakarta 24
San Francisco 24
Bari 22
Dongguan 20
Augusta 19
Toronto 19
Vienna 19
Palermo 16
San Mateo 16
Shanghai 16
Lappeenranta 15
Amsterdam 14
Cambridge 13
Frankfurt am Main 13
Bergamo 12
Newark 12
Ardabil 11
Wuhan 11
Clearwater 10
Isola della Scala 10
Perugia 10
Pozza 10
Qingdao 10
Bolzano 9
London 9
Riga 9
Stockholm 9
Colombo 8
Groningen 8
Leawood 8
Nürnberg 8
Pisa 8
Riva 8
San Diego 8
Sofia 8
Totale 20.842
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 816
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 521
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 293
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 169
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 157
Schwannoma del rene 155
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 155
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 153
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 149
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 148
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 146
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 140
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 135
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 134
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 134
Chondroid syringoma with extensive ossification 130
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 126
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 126
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 125
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 123
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 122
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 122
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 121
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 121
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 120
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 120
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 120
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 119
CD10 is expressed in a subset of chromophobe renal cell carcinomas 117
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 117
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 115
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 114
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 113
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 113
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 112
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 112
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 112
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 112
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 112
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 112
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 111
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 111
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 110
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 110
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 110
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 109
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 108
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 108
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 108
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 107
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 107
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 106
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 106
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 106
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 106
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 106
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 106
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 106
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 106
Pediatric optic nerve sheath meningioma 105
Espressione di CD23 nelle neoplasie cutanee annessiali 104
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 104
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 104
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 104
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 103
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 103
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 102
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 102
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 101
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 100
Rapid screening for malignancy in organ donors. 15 years experience with the Verona "Alert" protocol and review of the literature 100
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 99
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 99
Parvalbumin is constantly expressed in chromophobe renal carcinoma. 98
Adenocarcinoma of the paraurethral glands: a case report 98
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 97
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 97
Ependymoma with diffuse signet-ring features: report of a case and review of the literature 97
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 97
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 97
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 96
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 96
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 96
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy 96
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 96
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 96
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 96
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 96
[Diagnostic and prognostic markers in renal tumors] 95
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 95
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 95
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or Progression 95
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 95
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 95
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 95
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 94
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 94
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta 94
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 93
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 93
Totale 12.420
Categoria #
all - tutte 121.421
article - articoli 109.205
book - libri 0
conference - conferenze 11.978
curatela - curatele 0
other - altro 238
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 242.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.301 0 0 0 0 0 447 400 181 177 333 308 455
2020/20213.742 351 616 231 540 534 355 105 150 124 62 416 258
2021/20223.076 333 739 51 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20244.081 172 300 332 447 481 669 199 246 67 279 638 251
2024/20253.796 507 544 549 1.656 428 112 0 0 0 0 0 0
Totale 31.871